ctrl K

IDEAYA Biosciences Inc. (IDYA)

NASDAQ: IDYA · Real-Time Price · USD

20.47

0.34 (1.69%)

At close: May 01, 2025, 3:59 PM

20.58

0.54%

After-hours: May 01, 2025, 07:46 PM EDT

IDEAYA Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	7M	23.39M	50.93M	27.94M	19.54M	n/a	n/a	n/a
Cost of Revenue	3.83M	4.01M	2.1M	1.73M	39.7M	1.25M	886K	391K
Gross Profit	3.17M	19.38M	48.83M	26.22M	-20.16M	-1.25M	-886K	-391K
Operating Income	-326.98M	-134.43M	-62.5M	-50.27M	-35.34M	-44.27M	-36.42M	-14.44M
Interest Income	52.5M	21.47M	3.85M	506K	849K	2.29M	1.99M	150K
Pretax Income	-274.48M	-112.96M	-58.66M	-49.76M	-34.49M	-41.98M	-34.35M	-11.86M
Net Income	-274.48M	-112.96M	-54.81M	-47.53M	-32.27M	-38.44M	-34.35M	-11.86M
Selling & General & Admin	39.3M	28.31M	23.9M	20.05M	15.18M	9.95M	4.67M	2.05M
Research & Development	294.67M	129.51M	89.54M	58.16M	39.7M	34.32M	31.75M	12.38M
Other Expenses	n/a	n/a	n/a	n/a	n/a	8K	77K	2.43M
Operating Expenses	333.98M	157.81M	113.43M	78.21M	54.88M	44.27M	36.42M	14.44M
Interest Expense	n/a	n/a	3.85M	n/a	849K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	333.98M	157.81M	113.43M	78.21M	54.88M	44.27M	36.42M	14.44M
Income Tax Expense	n/a	n/a	-3.85M	-2.23M	-2.23M	-3.53M	2.07M	-150K
Shares Outstanding (Basic)	81.68M	57.52M	41.44M	35.25M	24.72M	20.23M	14.24M	14.24M
Shares Outstanding (Diluted)	81.68M	57.52M	41.44M	35.25M	24.72M	20.23M	14.24M	14.24M
EPS (Basic)	-3.36	-1.96	-1.32	-1.35	-1.31	-1.9	-2.41	-0.83
EPS (Diluted)	-3.36	-1.96	-1.32	-1.35	-1.31	-1.9	-2.41	-0.83
EBITDA	-326.98M	-130.42M	-60.4M	-48.54M	-33.96M	-43.03M	-35.53M	-14.05M
EBIT	-326.98M	-134.43M	-62.5M	-50.27M	-35.34M	-44.27M	-36.42M	-14.44M
Depreciation & Amortization	n/a	4.01M	2.1M	1.73M	1.38M	1.25M	886K	391K